APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Contaminants Detection and Analysis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Contaminants Detection and Analysis Market Analysis and Forecast 2026-2032

4 June 2026250 pages

Choose your research edition.

Industry ResearchDrug Contaminants Detection and Analysis Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Contaminants Detection and Analysis Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Contaminants Detection and Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Contaminants Detection and Analysis Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Contaminants Detection and Analysis Market Analysis and Forecast 2026-2032250 pages · $4,950 USD

Market perspective

The global Drug Contaminants Detection and Analysis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Contaminants Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Contaminants Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Contaminants Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Contaminants Detection and Analysis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Contaminants Detection and Analysis include Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek (UK), Thermo Fisher Scientific (USA), Charles River Laboratories (USA), Labcorp Biopharma (USA), WuXi STA / WuXi AppTec (China), Cambrex (USA) and Pharmaron (China), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Contaminants Detection and Analysis, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Contaminants Detection and Analysis, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Contaminants Detection and Analysis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Contaminants Detection and Analysis revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Contaminants Detection and Analysis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Contaminants Detection and Analysis revenue, projected growth trends, production technology, application and end-user industry.

Drug Contaminants Detection and Analysis Segment by Company

Eurofins Scientific (Luxembourg)

SGS (Switzerland)

Intertek (UK)

Thermo Fisher Scientific (USA)

Charles River Laboratories (USA)

Labcorp Biopharma (USA)

WuXi STA / WuXi AppTec (China)

Cambrex (USA)

Pharmaron (China)

Piramal Pharma Solutions (India)

Syngene (India)

Recipharm (Sweden)

Almac Sciences (UK)

MedPharm (UK)

CMIC (Japan)

Aenova (Germany)

Sterling Pharma Solutions (UK)

Curia (USA)

Ardena (Belgium)

Hovione (Portugal)

Delpharm (France)

AGC Biologics (USA)

FUJIFILM Biotechnologies (Japan)

KBI Biopharma (USA)

Rentschler Biopharma (Germany)

Ajinomoto Bio-Pharma Services (Japan)

Bora Pharmaceuticals (Taiwan, China)

Kindeva (USA)

CordenPharma (Switzerland)

RSSL (UK)

Tentamus (Germany)

Element Materials Technology (UK)

Nucro-Technics (Canada)

ALS (Australia)

Aizant (India)

Wickham Laboratories (UK)

Toxikon (USA)

Evotec (Germany)

Drug Contaminants Detection and Analysis Segment by Type

Organic Pollutant Detection Products

Inorganic Pollutant Detection Products

Others

Drug Contaminants Detection and Analysis Segment by Application

Chemical Pharmaceutical Industry

Biopharmaceutical Industry

Traditional Chinese Medicine and Natural Medicine Industry

Others

Drug Contaminants Detection and Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Contaminants Detection and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Contaminants Detection and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Contaminants Detection and Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Contaminants Detection and Analysis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Contaminants Detection and Analysis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Contaminants Detection and Analysis revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Organic Pollutant Detection Products Major Player Table 3. Inorganic Pollutant Detection Products Major Player Table 4. Others Major Player Table 5. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Chemical Pharmaceutical Industry Major Player Table 7. Biopharmaceutical Industry Major Player Table 8. Traditional Chinese Medicine and Natural Medicine Industry Major Player Table 9. Others Major Player Table 10. Drug Contaminants Detection and Analysis Industry Trends Table 11. Drug Contaminants Detection and Analysis Industry Drivers Table 12. Drug Contaminants Detection and Analysis Industry Opportunities and Challenges Table 13. Drug Contaminants Detection and Analysis Industry Restraints Table 14. Global Drug Contaminants Detection and Analysis Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Drug Contaminants Detection and Analysis Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Drug Contaminants Detection and Analysis Market Share by Region (2021-2026) Table 17. Global Drug Contaminants Detection and Analysis Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Drug Contaminants Detection and Analysis Market Share by Region (2027-2032) Table 19. Global Drug Contaminants Detection and Analysis Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Drug Contaminants Detection and Analysis Revenue Market Share by Players (2021-2026) Table 21. Global Drug Contaminants Detection and Analysis Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Drug Contaminants Detection and Analysis Key Players Headquarters & Area Served Table 23. Global Drug Contaminants Detection and Analysis Players, Product Type & Application Table 24. Global Drug Contaminants Detection and Analysis Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Drug Contaminants Detection and Analysis by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Drug Contaminants Detection and Analysis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drug Contaminants Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Drug Contaminants Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2021-2026) Table 31. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2027-2032) Table 32. Global Drug Contaminants Detection and Analysis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Contaminants Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Drug Contaminants Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2021-2026) Table 36. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2027-2032) Table 37. Eurofins Scientific (Luxembourg) Company Information Table 38. Eurofins Scientific (Luxembourg) Business Overview Table 39. Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio Table 41. Eurofins Scientific (Luxembourg) Recent Development Table 42. SGS (Switzerland) Company Information Table 43. SGS (Switzerland) Business Overview Table 44. SGS (Switzerland) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 46. SGS (Switzerland) Recent Development Table 47. Intertek (UK) Company Information Table 48. Intertek (UK) Business Overview Table 49. Intertek (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 51. Intertek (UK) Recent Development Table 52. Thermo Fisher Scientific (USA) Company Information Table 53. Thermo Fisher Scientific (USA) Business Overview Table 54. Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 56. Thermo Fisher Scientific (USA) Recent Development Table 57. Charles River Laboratories (USA) Company Information Table 58. Charles River Laboratories (USA) Business Overview Table 59. Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 61. Charles River Laboratories (USA) Recent Development Table 62. Labcorp Biopharma (USA) Company Information Table 63. Labcorp Biopharma (USA) Business Overview Table 64. Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 66. Labcorp Biopharma (USA) Recent Development Table 67. WuXi STA / WuXi AppTec (China) Company Information Table 68. WuXi STA / WuXi AppTec (China) Business Overview Table 69. WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio Table 71. WuXi STA / WuXi AppTec (China) Recent Development Table 72. Cambrex (USA) Company Information Table 73. Cambrex (USA) Business Overview Table 74. Cambrex (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 76. Cambrex (USA) Recent Development Table 77. Pharmaron (China) Company Information Table 78. Pharmaron (China) Business Overview Table 79. Pharmaron (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio Table 81. Pharmaron (China) Recent Development Table 82. Piramal Pharma Solutions (India) Company Information Table 83. Piramal Pharma Solutions (India) Business Overview Table 84. Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio Table 86. Piramal Pharma Solutions (India) Recent Development Table 87. Syngene (India) Company Information Table 88. Syngene (India) Business Overview Table 89. Syngene (India) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio Table 91. Syngene (India) Recent Development Table 92. Recipharm (Sweden) Company Information Table 93. Recipharm (Sweden) Business Overview Table 94. Recipharm (Sweden) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio Table 96. Recipharm (Sweden) Recent Development Table 97. Almac Sciences (UK) Company Information Table 98. Almac Sciences (UK) Business Overview Table 99. Almac Sciences (UK) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 101. Almac Sciences (UK) Recent Development Table 102. MedPharm (UK) Company Information Table 103. MedPharm (UK) Business Overview Table 104. MedPharm (UK) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 106. MedPharm (UK) Recent Development Table 107. CMIC (Japan) Company Information Table 108. CMIC (Japan) Business Overview Table 109. CMIC (Japan) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 111. CMIC (Japan) Recent Development Table 112. Aenova (Germany) Company Information Table 113. Aenova (Germany) Business Overview Table 114. Aenova (Germany) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 116. Aenova (Germany) Recent Development Table 117. Sterling Pharma Solutions (UK) Company Information Table 118. Sterling Pharma Solutions (UK) Business Overview Table 119. Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 121. Sterling Pharma Solutions (UK) Recent Development Table 122. Curia (USA) Company Information Table 123. Curia (USA) Business Overview Table 124. Curia (USA) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 126. Curia (USA) Recent Development Table 127. Ardena (Belgium) Company Information Table 128. Ardena (Belgium) Business Overview Table 129. Ardena (Belgium) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio Table 131. Ardena (Belgium) Recent Development Table 132. Hovione (Portugal) Company Information Table 133. Hovione (Portugal) Business Overview Table 134. Hovione (Portugal) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio Table 136. Hovione (Portugal) Recent Development Table 137. Delpharm (France) Company Information Table 138. Delpharm (France) Business Overview Table 139. Delpharm (France) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio Table 141. Delpharm (France) Recent Development Table 142. AGC Biologics (USA) Company Information Table 143. AGC Biologics (USA) Business Overview Table 144. AGC Biologics (USA) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 146. AGC Biologics (USA) Recent Development Table 147. FUJIFILM Biotechnologies (Japan) Company Information Table 148. FUJIFILM Biotechnologies (Japan) Business Overview Table 149. FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 151. FUJIFILM Biotechnologies (Japan) Recent Development Table 152. KBI Biopharma (USA) Company Information Table 153. KBI Biopharma (USA) Business Overview Table 154. KBI Biopharma (USA) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 156. KBI Biopharma (USA) Recent Development Table 157. Rentschler Biopharma (Germany) Company Information Table 158. Rentschler Biopharma (Germany) Business Overview Table 159. Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 161. Rentschler Biopharma (Germany) Recent Development Table 162. Ajinomoto Bio-Pharma Services (Japan) Company Information Table 163. Ajinomoto Bio-Pharma Services (Japan) Business Overview Table 164. Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio Table 166. Ajinomoto Bio-Pharma Services (Japan) Recent Development Table 167. Bora Pharmaceuticals (Taiwan, China) Company Information Table 168. Bora Pharmaceuticals (Taiwan, China) Business Overview Table 169. Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio Table 171. Bora Pharmaceuticals (Taiwan, China) Recent Development Table 172. Kindeva (USA) Company Information Table 173. Kindeva (USA) Business Overview Table 174. Kindeva (USA) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 176. Kindeva (USA) Recent Development Table 177. CordenPharma (Switzerland) Company Information Table 178. CordenPharma (Switzerland) Business Overview Table 179. CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio Table 181. CordenPharma (Switzerland) Recent Development Table 182. RSSL (UK) Company Information Table 183. RSSL (UK) Business Overview Table 184. RSSL (UK) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 185. RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 186. RSSL (UK) Recent Development Table 187. Tentamus (Germany) Company Information Table 188. Tentamus (Germany) Business Overview Table 189. Tentamus (Germany) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 190. Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 191. Tentamus (Germany) Recent Development Table 192. Element Materials Technology (UK) Company Information Table 193. Element Materials Technology (UK) Business Overview Table 194. Element Materials Technology (UK) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 195. Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 196. Element Materials Technology (UK) Recent Development Table 197. Nucro-Technics (Canada) Company Information Table 198. Nucro-Technics (Canada) Business Overview Table 199. Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 200. Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio Table 201. Nucro-Technics (Canada) Recent Development Table 202. ALS (Australia) Company Information Table 203. ALS (Australia) Business Overview Table 204. ALS (Australia) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 205. ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio Table 206. ALS (Australia) Recent Development Table 207. Aizant (India) Company Information Table 208. Aizant (India) Business Overview Table 209. Aizant (India) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 210. Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio Table 211. Aizant (India) Recent Development Table 212. Wickham Laboratories (UK) Company Information Table 213. Wickham Laboratories (UK) Business Overview Table 214. Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 215. Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio Table 216. Wickham Laboratories (UK) Recent Development Table 217. Toxikon (USA) Company Information Table 218. Toxikon (USA) Business Overview Table 219. Toxikon (USA) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 220. Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio Table 221. Toxikon (USA) Recent Development Table 222. Evotec (Germany) Company Information Table 223. Evotec (Germany) Business Overview Table 224. Evotec (Germany) Drug Contaminants Detection and Analysis Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 225. Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio Table 226. Evotec (Germany) Recent Development Table 227. North America Drug Contaminants Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 228. North America Drug Contaminants Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 229. North America Drug Contaminants Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 230. North America Drug Contaminants Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 231. North America Drug Contaminants Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 232. North America Drug Contaminants Detection and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 233. North America Drug Contaminants Detection and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 234. Europe Drug Contaminants Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 235. Europe Drug Contaminants Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 236. Europe Drug Contaminants Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 237. Europe Drug Contaminants Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 238. Europe Drug Contaminants Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. Europe Drug Contaminants Detection and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 240. Europe Drug Contaminants Detection and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 241. China Drug Contaminants Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 242. China Drug Contaminants Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 243. China Drug Contaminants Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 244. China Drug Contaminants Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 245. Asia Drug Contaminants Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 246. Asia Drug Contaminants Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 247. Asia Drug Contaminants Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 248. Asia Drug Contaminants Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 249. Asia Drug Contaminants Detection and Analysis Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 250. Asia Drug Contaminants Detection and Analysis Revenue by Region (US$ Million) & (2021-2026) Table 251. Asia Drug Contaminants Detection and Analysis Revenue by Region (US$ Million) & (2027-2032) Table 252. SAMEA Drug Contaminants Detection and Analysis Revenue by Type (2021-2026) & (US$ Million) Table 253. SAMEA Drug Contaminants Detection and Analysis Revenue by Type (2027-2032) & (US$ Million) Table 254. SAMEA Drug Contaminants Detection and Analysis Revenue by Application (2021-2026) & (US$ Million) Table 255. SAMEA Drug Contaminants Detection and Analysis Revenue by Application (2027-2032) & (US$ Million) Table 256. SAMEA Drug Contaminants Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 257. SAMEA Drug Contaminants Detection and Analysis Revenue by Country (2021-2026) & (US$ Million) Table 258. SAMEA Drug Contaminants Detection and Analysis Revenue by Country (US$ Million) & (2027-2032) Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Drug Contaminants Detection and Analysis Image Figure 2. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Contaminants Detection and Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Organic Pollutant Detection Products Image Figure 5. Inorganic Pollutant Detection Products Image Figure 6. Others Image Figure 7. Global Drug Contaminants Detection and Analysis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug Contaminants Detection and Analysis Market Size Share 2021 VS 2025 VS 2032 Figure 9. Chemical Pharmaceutical Industry Image Figure 10. Biopharmaceutical Industry Image Figure 11. Traditional Chinese Medicine and Natural Medicine Industry Image Figure 12. Others Image Figure 13. Global Drug Contaminants Detection and Analysis Market Size (US$ Million) & (2021-2032) Figure 14. Global Drug Contaminants Detection and Analysis Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Drug Contaminants Detection and Analysis Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Drug Contaminants Detection and Analysis Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drug Contaminants Detection and Analysis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Contaminants Detection and Analysis Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2021-2032) Figure 21. Global Drug Contaminants Detection and Analysis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2021-2032) Figure 24. North America Drug Contaminants Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032) Figure 26. North America Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032) Figure 27. North America Drug Contaminants Detection and Analysis Revenue Share by Country (2021-2032) Figure 28. United States Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Drug Contaminants Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032) Figure 33. Europe Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032) Figure 34. Europe Drug Contaminants Detection and Analysis Revenue Share by Country (2021-2032) Figure 35. Germany Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Drug Contaminants Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032) Figure 45. China Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032) Figure 46. Asia Drug Contaminants Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032) Figure 48. Asia Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032) Figure 49. Asia Drug Contaminants Detection and Analysis Revenue Share by Region (2021-2032) Figure 50. Japan Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Drug Contaminants Detection and Analysis Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032) Figure 58. SAMEA Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032) Figure 59. SAMEA Drug Contaminants Detection and Analysis Revenue Share by Country (2021-2032) Figure 60. Brazil Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Drug Contaminants Detection and Analysis Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Organic Pollutant Detection Products
  • Inorganic Pollutant Detection Products
  • Others
Applications
  • Chemical Pharmaceutical Industry
  • Biopharmaceutical Industry
  • Traditional Chinese Medicine and Natural Medicine Industry
  • Others
Companies covered
  • Eurofins Scientific (Luxembourg)
  • SGS (Switzerland)
  • Intertek (UK)
  • Thermo Fisher Scientific (USA)
  • Charles River Laboratories (USA)
  • Labcorp Biopharma (USA)
  • WuXi STA / WuXi AppTec (China)
  • Cambrex (USA)
  • Pharmaron (China)
  • Piramal Pharma Solutions (India)
  • Syngene (India)
  • Recipharm (Sweden)
  • Almac Sciences (UK)
  • MedPharm (UK)
  • CMIC (Japan)
  • Aenova (Germany)
  • Sterling Pharma Solutions (UK)
  • Curia (USA)
  • Ardena (Belgium)
  • Hovione (Portugal)
  • Delpharm (France)
  • AGC Biologics (USA)
  • FUJIFILM Biotechnologies (Japan)
  • KBI Biopharma (USA)
  • Rentschler Biopharma (Germany)
  • Ajinomoto Bio-Pharma Services (Japan)
  • Bora Pharmaceuticals (Taiwan, China)
  • Kindeva (USA)
  • CordenPharma (Switzerland)
  • RSSL (UK)
  • Tentamus (Germany)
  • Element Materials Technology (UK)
  • Nucro-Technics (Canada)
  • ALS (Australia)
  • Aizant (India)
  • Wickham Laboratories (UK)
  • Toxikon (USA)
  • Evotec (Germany)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Contaminants Detection and Analysis Market by Type
  3. 1.2.1 Global Drug Contaminants Detection and Analysis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Organic Pollutant Detection Products
  5. 1.2.3 Inorganic Pollutant Detection Products
  6. 1.2.4 Others
  7. 1.3 Drug Contaminants Detection and Analysis Market by Application
  8. 1.3.1 Global Drug Contaminants Detection and Analysis Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Chemical Pharmaceutical Industry
  10. 1.3.3 Biopharmaceutical Industry
  11. 1.3.4 Traditional Chinese Medicine and Natural Medicine Industry
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Drug Contaminants Detection and Analysis Market Dynamics
  1. 2.1 Drug Contaminants Detection and Analysis Industry Trends
  2. 2.2 Drug Contaminants Detection and Analysis Industry Drivers
  3. 2.3 Drug Contaminants Detection and Analysis Industry Opportunities and Challenges
  4. 2.4 Drug Contaminants Detection and Analysis Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Contaminants Detection and Analysis Market Perspective (2021-2032)
  2. 3.2 Global Drug Contaminants Detection and Analysis Growth Trends by Region
  3. 3.2.1 Global Drug Contaminants Detection and Analysis Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Contaminants Detection and Analysis Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Contaminants Detection and Analysis Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Contaminants Detection and Analysis Revenue by Players
  2. 4.1.1 Global Drug Contaminants Detection and Analysis Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Contaminants Detection and Analysis Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Contaminants Detection and Analysis Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Contaminants Detection and Analysis Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Contaminants Detection and Analysis Key Players Headquarters & Area Served
  7. 4.4 Global Drug Contaminants Detection and Analysis Players, Product Type & Application
  8. 4.5 Global Drug Contaminants Detection and Analysis Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Contaminants Detection and Analysis Market CR5 and HHI
  11. 4.6.3 2025 Drug Contaminants Detection and Analysis Tier 1, Tier 2, and Tier 3
5 Drug Contaminants Detection and Analysis Market Size by Type
  1. 5.1 Global Drug Contaminants Detection and Analysis Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Contaminants Detection and Analysis Revenue by Type (2021-2032)
  3. 5.3 Global Drug Contaminants Detection and Analysis Revenue Market Share by Type (2021-2032)
6 Drug Contaminants Detection and Analysis Market Size by Application
  1. 6.1 Global Drug Contaminants Detection and Analysis Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Contaminants Detection and Analysis Revenue by Application (2021-2032)
  3. 6.3 Global Drug Contaminants Detection and Analysis Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Scientific (Luxembourg)
  2. 7.1.1 Eurofins Scientific (Luxembourg) Company Information
  3. 7.1.2 Eurofins Scientific (Luxembourg) Business Overview
  4. 7.1.3 Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Scientific (Luxembourg) Drug Contaminants Detection and Analysis Product Portfolio
  6. 7.1.5 Eurofins Scientific (Luxembourg) Recent Developments
  7. 7.2 SGS (Switzerland)
  8. 7.2.1 SGS (Switzerland) Company Information
  9. 7.2.2 SGS (Switzerland) Business Overview
  10. 7.2.3 SGS (Switzerland) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  11. 7.2.4 SGS (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  12. 7.2.5 SGS (Switzerland) Recent Developments
  13. 7.3 Intertek (UK)
  14. 7.3.1 Intertek (UK) Company Information
  15. 7.3.2 Intertek (UK) Business Overview
  16. 7.3.3 Intertek (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Intertek (UK) Drug Contaminants Detection and Analysis Product Portfolio
  18. 7.3.5 Intertek (UK) Recent Developments
  19. 7.4 Thermo Fisher Scientific (USA)
  20. 7.4.1 Thermo Fisher Scientific (USA) Company Information
  21. 7.4.2 Thermo Fisher Scientific (USA) Business Overview
  22. 7.4.3 Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Scientific (USA) Drug Contaminants Detection and Analysis Product Portfolio
  24. 7.4.5 Thermo Fisher Scientific (USA) Recent Developments
  25. 7.5 Charles River Laboratories (USA)
  26. 7.5.1 Charles River Laboratories (USA) Company Information
  27. 7.5.2 Charles River Laboratories (USA) Business Overview
  28. 7.5.3 Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Charles River Laboratories (USA) Drug Contaminants Detection and Analysis Product Portfolio
  30. 7.5.5 Charles River Laboratories (USA) Recent Developments
  31. 7.6 Labcorp Biopharma (USA)
  32. 7.6.1 Labcorp Biopharma (USA) Company Information
  33. 7.6.2 Labcorp Biopharma (USA) Business Overview
  34. 7.6.3 Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Labcorp Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  36. 7.6.5 Labcorp Biopharma (USA) Recent Developments
  37. 7.7 WuXi STA / WuXi AppTec (China)
  38. 7.7.1 WuXi STA / WuXi AppTec (China) Company Information
  39. 7.7.2 WuXi STA / WuXi AppTec (China) Business Overview
  40. 7.7.3 WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  41. 7.7.4 WuXi STA / WuXi AppTec (China) Drug Contaminants Detection and Analysis Product Portfolio
  42. 7.7.5 WuXi STA / WuXi AppTec (China) Recent Developments
  43. 7.8 Cambrex (USA)
  44. 7.8.1 Cambrex (USA) Company Information
  45. 7.8.2 Cambrex (USA) Business Overview
  46. 7.8.3 Cambrex (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Cambrex (USA) Drug Contaminants Detection and Analysis Product Portfolio
  48. 7.8.5 Cambrex (USA) Recent Developments
  49. 7.9 Pharmaron (China)
  50. 7.9.1 Pharmaron (China) Company Information
  51. 7.9.2 Pharmaron (China) Business Overview
  52. 7.9.3 Pharmaron (China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pharmaron (China) Drug Contaminants Detection and Analysis Product Portfolio
  54. 7.9.5 Pharmaron (China) Recent Developments
  55. 7.10 Piramal Pharma Solutions (India)
  56. 7.10.1 Piramal Pharma Solutions (India) Company Information
  57. 7.10.2 Piramal Pharma Solutions (India) Business Overview
  58. 7.10.3 Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Piramal Pharma Solutions (India) Drug Contaminants Detection and Analysis Product Portfolio
  60. 7.10.5 Piramal Pharma Solutions (India) Recent Developments
  61. 7.11 Syngene (India)
  62. 7.11.1 Syngene (India) Company Information
  63. 7.11.2 Syngene (India) Business Overview
  64. 7.11.3 Syngene (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Syngene (India) Drug Contaminants Detection and Analysis Product Portfolio
  66. 7.11.5 Syngene (India) Recent Developments
  67. 7.12 Recipharm (Sweden)
  68. 7.12.1 Recipharm (Sweden) Company Information
  69. 7.12.2 Recipharm (Sweden) Business Overview
  70. 7.12.3 Recipharm (Sweden) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Recipharm (Sweden) Drug Contaminants Detection and Analysis Product Portfolio
  72. 7.12.5 Recipharm (Sweden) Recent Developments
  73. 7.13 Almac Sciences (UK)
  74. 7.13.1 Almac Sciences (UK) Company Information
  75. 7.13.2 Almac Sciences (UK) Business Overview
  76. 7.13.3 Almac Sciences (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Almac Sciences (UK) Drug Contaminants Detection and Analysis Product Portfolio
  78. 7.13.5 Almac Sciences (UK) Recent Developments
  79. 7.14 MedPharm (UK)
  80. 7.14.1 MedPharm (UK) Company Information
  81. 7.14.2 MedPharm (UK) Business Overview
  82. 7.14.3 MedPharm (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  83. 7.14.4 MedPharm (UK) Drug Contaminants Detection and Analysis Product Portfolio
  84. 7.14.5 MedPharm (UK) Recent Developments
  85. 7.15 CMIC (Japan)
  86. 7.15.1 CMIC (Japan) Company Information
  87. 7.15.2 CMIC (Japan) Business Overview
  88. 7.15.3 CMIC (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CMIC (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  90. 7.15.5 CMIC (Japan) Recent Developments
  91. 7.16 Aenova (Germany)
  92. 7.16.1 Aenova (Germany) Company Information
  93. 7.16.2 Aenova (Germany) Business Overview
  94. 7.16.3 Aenova (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Aenova (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  96. 7.16.5 Aenova (Germany) Recent Developments
  97. 7.17 Sterling Pharma Solutions (UK)
  98. 7.17.1 Sterling Pharma Solutions (UK) Company Information
  99. 7.17.2 Sterling Pharma Solutions (UK) Business Overview
  100. 7.17.3 Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Sterling Pharma Solutions (UK) Drug Contaminants Detection and Analysis Product Portfolio
  102. 7.17.5 Sterling Pharma Solutions (UK) Recent Developments
  103. 7.18 Curia (USA)
  104. 7.18.1 Curia (USA) Company Information
  105. 7.18.2 Curia (USA) Business Overview
  106. 7.18.3 Curia (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Curia (USA) Drug Contaminants Detection and Analysis Product Portfolio
  108. 7.18.5 Curia (USA) Recent Developments
  109. 7.19 Ardena (Belgium)
  110. 7.19.1 Ardena (Belgium) Company Information
  111. 7.19.2 Ardena (Belgium) Business Overview
  112. 7.19.3 Ardena (Belgium) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Ardena (Belgium) Drug Contaminants Detection and Analysis Product Portfolio
  114. 7.19.5 Ardena (Belgium) Recent Developments
  115. 7.20 Hovione (Portugal)
  116. 7.20.1 Hovione (Portugal) Company Information
  117. 7.20.2 Hovione (Portugal) Business Overview
  118. 7.20.3 Hovione (Portugal) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Hovione (Portugal) Drug Contaminants Detection and Analysis Product Portfolio
  120. 7.20.5 Hovione (Portugal) Recent Developments
  121. 7.21 Delpharm (France)
  122. 7.21.1 Delpharm (France) Company Information
  123. 7.21.2 Delpharm (France) Business Overview
  124. 7.21.3 Delpharm (France) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Delpharm (France) Drug Contaminants Detection and Analysis Product Portfolio
  126. 7.21.5 Delpharm (France) Recent Developments
  127. 7.22 AGC Biologics (USA)
  128. 7.22.1 AGC Biologics (USA) Company Information
  129. 7.22.2 AGC Biologics (USA) Business Overview
  130. 7.22.3 AGC Biologics (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  131. 7.22.4 AGC Biologics (USA) Drug Contaminants Detection and Analysis Product Portfolio
  132. 7.22.5 AGC Biologics (USA) Recent Developments
  133. 7.23 FUJIFILM Biotechnologies (Japan)
  134. 7.23.1 FUJIFILM Biotechnologies (Japan) Company Information
  135. 7.23.2 FUJIFILM Biotechnologies (Japan) Business Overview
  136. 7.23.3 FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  137. 7.23.4 FUJIFILM Biotechnologies (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  138. 7.23.5 FUJIFILM Biotechnologies (Japan) Recent Developments
  139. 7.24 KBI Biopharma (USA)
  140. 7.24.1 KBI Biopharma (USA) Company Information
  141. 7.24.2 KBI Biopharma (USA) Business Overview
  142. 7.24.3 KBI Biopharma (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  143. 7.24.4 KBI Biopharma (USA) Drug Contaminants Detection and Analysis Product Portfolio
  144. 7.24.5 KBI Biopharma (USA) Recent Developments
  145. 7.25 Rentschler Biopharma (Germany)
  146. 7.25.1 Rentschler Biopharma (Germany) Company Information
  147. 7.25.2 Rentschler Biopharma (Germany) Business Overview
  148. 7.25.3 Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  149. 7.25.4 Rentschler Biopharma (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  150. 7.25.5 Rentschler Biopharma (Germany) Recent Developments
  151. 7.26 Ajinomoto Bio-Pharma Services (Japan)
  152. 7.26.1 Ajinomoto Bio-Pharma Services (Japan) Company Information
  153. 7.26.2 Ajinomoto Bio-Pharma Services (Japan) Business Overview
  154. 7.26.3 Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  155. 7.26.4 Ajinomoto Bio-Pharma Services (Japan) Drug Contaminants Detection and Analysis Product Portfolio
  156. 7.26.5 Ajinomoto Bio-Pharma Services (Japan) Recent Developments
  157. 7.27 Bora Pharmaceuticals (Taiwan, China)
  158. 7.27.1 Bora Pharmaceuticals (Taiwan, China) Company Information
  159. 7.27.2 Bora Pharmaceuticals (Taiwan, China) Business Overview
  160. 7.27.3 Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  161. 7.27.4 Bora Pharmaceuticals (Taiwan, China) Drug Contaminants Detection and Analysis Product Portfolio
  162. 7.27.5 Bora Pharmaceuticals (Taiwan, China) Recent Developments
  163. 7.28 Kindeva (USA)
  164. 7.28.1 Kindeva (USA) Company Information
  165. 7.28.2 Kindeva (USA) Business Overview
  166. 7.28.3 Kindeva (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  167. 7.28.4 Kindeva (USA) Drug Contaminants Detection and Analysis Product Portfolio
  168. 7.28.5 Kindeva (USA) Recent Developments
  169. 7.29 CordenPharma (Switzerland)
  170. 7.29.1 CordenPharma (Switzerland) Company Information
  171. 7.29.2 CordenPharma (Switzerland) Business Overview
  172. 7.29.3 CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  173. 7.29.4 CordenPharma (Switzerland) Drug Contaminants Detection and Analysis Product Portfolio
  174. 7.29.5 CordenPharma (Switzerland) Recent Developments
  175. 7.30 RSSL (UK)
  176. 7.30.1 RSSL (UK) Company Information
  177. 7.30.2 RSSL (UK) Business Overview
  178. 7.30.3 RSSL (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  179. 7.30.4 RSSL (UK) Drug Contaminants Detection and Analysis Product Portfolio
  180. 7.30.5 RSSL (UK) Recent Developments
  181. 7.31 Tentamus (Germany)
  182. 7.31.1 Tentamus (Germany) Company Information
  183. 7.31.2 Tentamus (Germany) Business Overview
  184. 7.31.3 Tentamus (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  185. 7.31.4 Tentamus (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  186. 7.31.5 Tentamus (Germany) Recent Developments
  187. 7.32 Element Materials Technology (UK)
  188. 7.32.1 Element Materials Technology (UK) Company Information
  189. 7.32.2 Element Materials Technology (UK) Business Overview
  190. 7.32.3 Element Materials Technology (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  191. 7.32.4 Element Materials Technology (UK) Drug Contaminants Detection and Analysis Product Portfolio
  192. 7.32.5 Element Materials Technology (UK) Recent Developments
  193. 7.33 Nucro-Technics (Canada)
  194. 7.33.1 Nucro-Technics (Canada) Company Information
  195. 7.33.2 Nucro-Technics (Canada) Business Overview
  196. 7.33.3 Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  197. 7.33.4 Nucro-Technics (Canada) Drug Contaminants Detection and Analysis Product Portfolio
  198. 7.33.5 Nucro-Technics (Canada) Recent Developments
  199. 7.34 ALS (Australia)
  200. 7.34.1 ALS (Australia) Company Information
  201. 7.34.2 ALS (Australia) Business Overview
  202. 7.34.3 ALS (Australia) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  203. 7.34.4 ALS (Australia) Drug Contaminants Detection and Analysis Product Portfolio
  204. 7.34.5 ALS (Australia) Recent Developments
  205. 7.35 Aizant (India)
  206. 7.35.1 Aizant (India) Company Information
  207. 7.35.2 Aizant (India) Business Overview
  208. 7.35.3 Aizant (India) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  209. 7.35.4 Aizant (India) Drug Contaminants Detection and Analysis Product Portfolio
  210. 7.35.5 Aizant (India) Recent Developments
  211. 7.36 Wickham Laboratories (UK)
  212. 7.36.1 Wickham Laboratories (UK) Company Information
  213. 7.36.2 Wickham Laboratories (UK) Business Overview
  214. 7.36.3 Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  215. 7.36.4 Wickham Laboratories (UK) Drug Contaminants Detection and Analysis Product Portfolio
  216. 7.36.5 Wickham Laboratories (UK) Recent Developments
  217. 7.37 Toxikon (USA)
  218. 7.37.1 Toxikon (USA) Company Information
  219. 7.37.2 Toxikon (USA) Business Overview
  220. 7.37.3 Toxikon (USA) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  221. 7.37.4 Toxikon (USA) Drug Contaminants Detection and Analysis Product Portfolio
  222. 7.37.5 Toxikon (USA) Recent Developments
  223. 7.38 Evotec (Germany)
  224. 7.38.1 Evotec (Germany) Company Information
  225. 7.38.2 Evotec (Germany) Business Overview
  226. 7.38.3 Evotec (Germany) Drug Contaminants Detection and Analysis Revenue and Gross Margin (2021-2026)
  227. 7.38.4 Evotec (Germany) Drug Contaminants Detection and Analysis Product Portfolio
  228. 7.38.5 Evotec (Germany) Recent Developments
8 North America
  1. 8.1 North America Drug Contaminants Detection and Analysis Revenue (2021-2032)
  2. 8.2 North America Drug Contaminants Detection and Analysis Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Contaminants Detection and Analysis Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Contaminants Detection and Analysis Revenue by Type (2027-2032)
  5. 8.3 North America Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Contaminants Detection and Analysis Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Contaminants Detection and Analysis Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Contaminants Detection and Analysis Revenue by Application (2027-2032)
  9. 8.5 North America Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Contaminants Detection and Analysis Revenue by Country
  11. 8.6.1 North America Drug Contaminants Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Contaminants Detection and Analysis Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Contaminants Detection and Analysis Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Contaminants Detection and Analysis Revenue (2021-2032)
  2. 9.2 Europe Drug Contaminants Detection and Analysis Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Contaminants Detection and Analysis Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Contaminants Detection and Analysis Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Contaminants Detection and Analysis Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Contaminants Detection and Analysis Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Contaminants Detection and Analysis Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Contaminants Detection and Analysis Revenue by Country
  11. 9.6.1 Europe Drug Contaminants Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Contaminants Detection and Analysis Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Contaminants Detection and Analysis Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Contaminants Detection and Analysis Revenue (2021-2032)
  2. 10.2 China Drug Contaminants Detection and Analysis Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Contaminants Detection and Analysis Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Contaminants Detection and Analysis Revenue by Type (2027-2032)
  5. 10.3 China Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Contaminants Detection and Analysis Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Contaminants Detection and Analysis Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Contaminants Detection and Analysis Revenue by Application (2027-2032)
  9. 10.5 China Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Contaminants Detection and Analysis Revenue (2021-2032)
  2. 11.2 Asia Drug Contaminants Detection and Analysis Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Contaminants Detection and Analysis Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Contaminants Detection and Analysis Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Contaminants Detection and Analysis Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Contaminants Detection and Analysis Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Contaminants Detection and Analysis Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Contaminants Detection and Analysis Revenue by Country
  11. 11.6.1 Asia Drug Contaminants Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Contaminants Detection and Analysis Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Contaminants Detection and Analysis Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Contaminants Detection and Analysis Revenue (2021-2032)
  2. 12.2 SAMEA Drug Contaminants Detection and Analysis Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Contaminants Detection and Analysis Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Contaminants Detection and Analysis Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Contaminants Detection and Analysis Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Contaminants Detection and Analysis Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Contaminants Detection and Analysis Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Contaminants Detection and Analysis Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Contaminants Detection and Analysis Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Contaminants Detection and Analysis Revenue by Country
  11. 12.6.1 SAMEA Drug Contaminants Detection and Analysis Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Contaminants Detection and Analysis Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Contaminants Detection and Analysis Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst